Cargando…
Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine
OBJECTIVES: Noroviruses (NoVs) are major cause of acute viral gastroenteritis in worldwide, and the lack of a cell culture system that must be considered the virus like particles (VLPs) are used as an effective vaccine development. MATERIALS AND METHODS: In the present study, we investigated the exp...
Autores principales: | Chen, Wei, Kang, Tao, Yuan, Rongliang, Shao, Congwen, Jing, Shenrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223773/ https://www.ncbi.nlm.nih.gov/pubmed/32088791 http://dx.doi.org/10.1007/s10529-020-02837-w |
Ejemplares similares
-
Evolutionary dynamics of GII.17 norovirus
por: Sang, Shaowei, et al.
Publicado: (2018) -
Immunogenicity and Blocking Efficacy of Norovirus GII.4 Recombinant P Protein Vaccine
por: Yu, Zhendi, et al.
Publicado: (2023) -
Molecular Evidence of Oysters as Vehicle of Norovirus GII.P17-GII.17
por: Rasmussen, Lasse Dam, et al.
Publicado: (2016) -
The endemic GII.4 norovirus‐like‐particle induced‐antibody lacks of cross‐reactivity against the epidemic GII.17 strain
por: Du, Jialiang, et al.
Publicado: (2020) -
Outbreak of Norovirus GII.P17-GII.17 in the Canadian Province of Nova Scotia
por: LeBlanc, Jason J., et al.
Publicado: (2016)